6 research outputs found

    Analysis of the influence of the different times of polymerization by incandescent light in composite resins by evaluation of its abrasive wear

    Get PDF
    No mercado atual a qualidade é necessária na fabricação dos produtos. No mercado odontológico, as resinas compostas são cada vez mais utilizadas para substituir materiais tradicionais, como amalgama, nas restaurações estéticas e funcionais, apresentando boa estética e funcionalidade. A composição química destes materiais é variável e os resultados das reações químicas do processo de polimerização são bastante desconhecidos. O objetivo deste trabalho era medir a resistência do desgaste abrasivo de seis resinas compostas vendidas no mercado brasileiro polimerizadas com tempos de 10, 20 e 40 segundos. O método do disco retificado modificado para aplicações em odontologia foi usado para tornar esta proposta viável. Neste banco de ensaios um disco dinâmico, revestido por porcelana, desgasta um disco estático revestido do tipo de resina que se pretende avaliar, que foi polimerizada durante um tempo pré-estabelecido. Com a determinação do desgaste de material, num determinado tempo, determinava-se a agressividade (capacidade de um material para desgastar outro material) do disco dinâmico sobre o disco estático. Utilizando-se para isso um programa computacional (LabView). Posteriormente era feita a regressão linear dos valores obtidos e determinado o coeficiente angular, utilizado no cálculo de agressividade. Valores elevados de agressividade indicam uma maior agressão do disco dinâmico contra o disco estático. Os resultados mostraram um comportamento variável para cada material que foi polimerizado nos diferentes tempos de polimerização utilizado, mostrando que o método para fazer estudos de desgaste é prático e rápido para testar materiais novos antes da sua utilização.1317787Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Não temIn the current market an increasing quality is demanded to manufacture products. At the odontologic market the composed resins are becoming more and more used to replace old materials, like amalgamates in the aesthetic and functional restorations, since they present a better appearance and easier manuscript. The chemical composition of these materials varies and the results of the chemical reactions of polymerization processes are quite unknown. The aim of this work was to measure the resistance of the abrasive wear of six composed resins sold in Brazilian market when displayed to polymerization periods of 10, 20 and 40 seconds. The grinding disc method appropriated for odontology was used to make this process possible. For this a bank of assays in which a porcelain covered dynamic disc consumes a static disc recovered by the polymerized resin is used to demonstrate the method in a pre-established time. The abrasive wear was determined by the calculation of the aggressiveness (capacity of a material to consume another). This aggressiveness is determined by an initial graph of displacement for time, through the computational method (LabView program). After they have passed through a linear regression the results give as a possibility the angular coefficient, considered a parameter at the calculation of aggressiveness. Higher values of aggressiveness which means a higher aggression suffered by the resin disc indicate worse resistance to the abrasive consuming of this resin in relation to porcelain. The results showed a variable comportment for each material ahead the different polymerization time, which prove the importance in create a practical and fast analyses method to test new materials before their us

    Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer

    No full text
    BACKGROUND The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the worldwide epidemiological evidence on the relation between breast cancer risk and use of hormonal contraceptives. METHODS Individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 studies conducted in 25 countries were collected, checked, and analysed centrally. Estimates of the relative risk for breast cancer were obtained by a modification of the Mantel-Haenszel method. All analyses were stratified by study, age at diagnosis, parity, and, where appropriate, the age a woman was when her first child was born, and the age she was when her risk of conception ceased. FINDINGS The results provide strong evidence for two main conclusions. First, while women are taking combined oral contraceptives and in the 10 years after stopping there is a small increase in the relative risk of having breast cancer diagnosed (relative risk [95 percent CI] in current users 1.24 [1.15-1.33], 2p<0.00001; 1-4 years after stopping 1.16 [1.08-1.23], 2p=0.00001; 5-9 years after stopping 1.07 [1.02-1.13], 2p=0.009). Second, there is no significant excess risk of having breast cancer diagnosed 10 or more years after stopping use (relative risk 1.01 [0.96-1.05], NS). The cancers diagnosed in women who had used combined oral contraceptives were less advanced clinically than those diagnosed in women who had never used these contraceptives for ever-users compared with never-users, the relative risk for tumours that had spread beyond the breast compared with localised tumours was 0.88 (0.81-0.95; 2p=0.002). There was no pronounced variation in the results for recency of use between women with different background risks of breast cancer, including women from different countries and ethnic groups, women with different reproductive histories, and those with or without a family history of breast cancer. The studies included in this collaboration represent about 90 percent of the epidemiological information on the topic, and what is known about the other studies suggests that their omission has not materially affected the main conclusions. Other features of hormonal contraceptive use such as duration of use, age at first use, and the dose and type of hormone within the contraceptives had little additional effect on breast cancer risk, once recency of use had been taken into account. Women who began use before age 20 had higher relative risks of having breast cancer diagnosed while they were using combined oral contraceptives and in the 5 years after stopping than women who began use at older ages, but the higher relative risks apply at ages when breast cancer is rare and, for a given duration of use, earlier use does not result in more cancers being diagnosed than use beginning at older ages. Because breast cancer incidence rises steeply with age, the estimated excess number of cancers diagnosed in the period between starting use and 10 years after stopping increases with age at last use: for example, among 10 000 women from Europe or North America who used oral contraceptives from age 16 to 19, from age 20 to 24, and from age 25 to 29, respectively, the estimated excess number of cancers diagnosed up to 10 years after stopping use is 0.5 (95 percent CI 0.3-0.7), 1.5 (0.7-2.3), and 4.7 (2.7-6.7). Up to 20 years after cessation of use the difference between ever-users and never-users is not so much in the total number of cancers diagnosed, but in their clinical presentation, with the breast cancers diagnosed in ever-users being less advanced clinically than those diagnosed in never-users. The relation observed between breast cancer risk and hormone exposure is unusual, and it is not possible to infer from these data whether it is due to an earlier diagnosis of breast cancer in ever-users, the biological effects of hormonal contraceptives, or a combination of reasons..

    Seismological studies of ZZ Ceti stars

    No full text
    10.1016/S0140-6736(97)08233-0Lancet35090841047-1059LANC

    CMS Physics Technical Design Report: Addendum on High Density QCD with Heavy Ions

    No full text
    This report presents the capabilities of the CMS experiment to explore the rich heavy-ion physics programme offered by the CERN Large Hadron Collider (LHC). The collisions of lead nuclei at energies sNN=5.5TeV\sqrt{s_{NN}}= 5.5\,{\rm TeV} , will probe quark and gluon matter at unprecedented values of energy density. The prime goal of this research is to study the fundamental theory of the strong interaction \u2014 Quantum Chromodynamics (QCD) \u2014 in extreme conditions of temperature, density and parton momentum fraction (low- x ). This report covers in detail the potential of CMS to carry out a series of representative Pb-Pb measurements. These include "bulk" observables, (charged hadron multiplicity, low p T inclusive hadron identified spectra and elliptic flow) which provide information on the collective properties of the system, as well as perturbative probes such as quarkonia, heavy-quarks, jets and high p T hadrons which yield "tomographic" information of the hottest and densest phases of the reaction
    corecore